Influence of CYP1A1, GSTM1, GSTT1, and NQO1 Genotypes and Cumulative Smoking Dose on Lung Cancer Risk in a Swedish Population

The major identified risk factor for lung cancer is tobacco smoking. We identified previously the possible modifying influence of CYP1A1 and GSTM1 polymorphisms on lung cancer risk in a Swedish population. The present study, extended by several study subjects and with analyses for polymorphisms in G...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2004-06, Vol.13 (6), p.908-914
Hauptverfasser: ALEXANDRIE, Anna-Karin, NYBERG, Fredrik, WARHOLM, Margareta, RANNUG, Agneta
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 914
container_issue 6
container_start_page 908
container_title Cancer epidemiology, biomarkers & prevention
container_volume 13
creator ALEXANDRIE, Anna-Karin
NYBERG, Fredrik
WARHOLM, Margareta
RANNUG, Agneta
description The major identified risk factor for lung cancer is tobacco smoking. We identified previously the possible modifying influence of CYP1A1 and GSTM1 polymorphisms on lung cancer risk in a Swedish population. The present study, extended by several study subjects and with analyses for polymorphisms in GSTT1 and NQO1 , includes 524 lung cancer cases and 530 control subjects. No evidence for an influence of genetic polymorphisms in CYP1A1 , GSTM1 , GSTT1 , and NQO1 on lung cancer risk overall was found. In smokers, there was, however, a suggestion that the variant CYP1A1 and NQO1 genotypes may confer an increased risk for squamous cell carcinoma. In ever smokers, the homozygously deleted GSTM1 ( GSTM1*O/*O ) genotype was significantly associated with increased risk of small cell carcinoma (adjusted odds ratio 2.72, 95% confidence interval 1.32-5.90). The risks noted for the variant CYP1A1 genotypes and the GSTM1*O/*O genotype seemed to be restricted to light smokers. The GSTT1*O/*O genotype also appeared to be a possible risk factor in light smokers, whereas, in heavy smokers, this genotype was associated with decreased risk for lung cancer overall (odds ratio 0.36, 95% confidence interval 0.13-0.99). Due to the multiple comparisons made, we cannot exclude the possibility that some of these associations may represent chance findings.
doi_str_mv 10.1158/1055-9965.908.13.6
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_585262</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72005207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-692001ec5731f15936cd3ce9821ed982c98afe6de88abfd8f66aa8a16f5e17143</originalsourceid><addsrcrecordid>eNpNkU2P0zAQhiMEYpeFP8AB-cJyIcWOa8c-rgKUlQq70HLgZLnOeGuaxMFuqPbAf8dpysfF86Fn3rHmzbLnBM8IYeINwYzlUnI2k1jMCJ3xB9k5YVTkZcnYw5T_Ac6yJzF-xxiXkrHH2RlhRMyLOTvPfl13thmgM4C8RdW3W3JFXqPFav1xCusUdFejT59vCFpA5_f3PcRjqxraodF79xPQqvU7192htz4mnQ4th1RUOqkG9MXFHXId0mh1gNrFLbr1_XHQd0-zR1Y3EZ6d4kX29f27dfUhX94srqurZW6olPucywJjAoaVlFjCJOWmpgakKAjU6TVSaAu8BiH0xtbCcq610IRbBqQkc3qR5ZNuPEA_bFQfXKvDvfLaqVNrlzJQTLCCF4m_nPg--B8DxL1qXTTQNLoDP0RVpv-wApcJLCbQBB9jAPtXmmA1mqRGD9TogUomKUIVT0MvTurDpoX638jJlQS8PAE6Gt3YkC7p4n-coJyJcfuridu6u-3BBVDmePMAEXQw2-O6cS_9DUwnpcM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72005207</pqid></control><display><type>article</type><title>Influence of CYP1A1, GSTM1, GSTT1, and NQO1 Genotypes and Cumulative Smoking Dose on Lung Cancer Risk in a Swedish Population</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><creator>ALEXANDRIE, Anna-Karin ; NYBERG, Fredrik ; WARHOLM, Margareta ; RANNUG, Agneta</creator><creatorcontrib>ALEXANDRIE, Anna-Karin ; NYBERG, Fredrik ; WARHOLM, Margareta ; RANNUG, Agneta</creatorcontrib><description>The major identified risk factor for lung cancer is tobacco smoking. We identified previously the possible modifying influence of CYP1A1 and GSTM1 polymorphisms on lung cancer risk in a Swedish population. The present study, extended by several study subjects and with analyses for polymorphisms in GSTT1 and NQO1 , includes 524 lung cancer cases and 530 control subjects. No evidence for an influence of genetic polymorphisms in CYP1A1 , GSTM1 , GSTT1 , and NQO1 on lung cancer risk overall was found. In smokers, there was, however, a suggestion that the variant CYP1A1 and NQO1 genotypes may confer an increased risk for squamous cell carcinoma. In ever smokers, the homozygously deleted GSTM1 ( GSTM1*O/*O ) genotype was significantly associated with increased risk of small cell carcinoma (adjusted odds ratio 2.72, 95% confidence interval 1.32-5.90). The risks noted for the variant CYP1A1 genotypes and the GSTM1*O/*O genotype seemed to be restricted to light smokers. The GSTT1*O/*O genotype also appeared to be a possible risk factor in light smokers, whereas, in heavy smokers, this genotype was associated with decreased risk for lung cancer overall (odds ratio 0.36, 95% confidence interval 0.13-0.99). Due to the multiple comparisons made, we cannot exclude the possibility that some of these associations may represent chance findings.</description><identifier>ISSN: 1055-9965</identifier><identifier>EISSN: 1538-7755</identifier><identifier>DOI: 10.1158/1055-9965.908.13.6</identifier><identifier>PMID: 15184245</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Carcinoma, Small Cell - epidemiology ; Carcinoma, Small Cell - genetics ; Carcinoma, Squamous Cell - epidemiology ; Carcinoma, Squamous Cell - genetics ; Case-Control Studies ; Cytochrome P-450 CYP1A1 - genetics ; Dose-Response Relationship, Drug ; Female ; Genetic Predisposition to Disease ; Genotype ; Glutathione Transferase - genetics ; Humans ; Lung Neoplasms - epidemiology ; Lung Neoplasms - genetics ; Male ; Medical sciences ; Middle Aged ; NAD(P)H Dehydrogenase (Quinone) - genetics ; Pneumology ; Polymorphism, Genetic ; Risk Factors ; Smoking - adverse effects ; Smoking - genetics ; Sweden - epidemiology ; Tumors of the respiratory system and mediastinum</subject><ispartof>Cancer epidemiology, biomarkers &amp; prevention, 2004-06, Vol.13 (6), p.908-914</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-692001ec5731f15936cd3ce9821ed982c98afe6de88abfd8f66aa8a16f5e17143</citedby><cites>FETCH-LOGICAL-c399t-692001ec5731f15936cd3ce9821ed982c98afe6de88abfd8f66aa8a16f5e17143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,3342,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15836587$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15184245$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:1930782$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>ALEXANDRIE, Anna-Karin</creatorcontrib><creatorcontrib>NYBERG, Fredrik</creatorcontrib><creatorcontrib>WARHOLM, Margareta</creatorcontrib><creatorcontrib>RANNUG, Agneta</creatorcontrib><title>Influence of CYP1A1, GSTM1, GSTT1, and NQO1 Genotypes and Cumulative Smoking Dose on Lung Cancer Risk in a Swedish Population</title><title>Cancer epidemiology, biomarkers &amp; prevention</title><addtitle>Cancer Epidemiol Biomarkers Prev</addtitle><description>The major identified risk factor for lung cancer is tobacco smoking. We identified previously the possible modifying influence of CYP1A1 and GSTM1 polymorphisms on lung cancer risk in a Swedish population. The present study, extended by several study subjects and with analyses for polymorphisms in GSTT1 and NQO1 , includes 524 lung cancer cases and 530 control subjects. No evidence for an influence of genetic polymorphisms in CYP1A1 , GSTM1 , GSTT1 , and NQO1 on lung cancer risk overall was found. In smokers, there was, however, a suggestion that the variant CYP1A1 and NQO1 genotypes may confer an increased risk for squamous cell carcinoma. In ever smokers, the homozygously deleted GSTM1 ( GSTM1*O/*O ) genotype was significantly associated with increased risk of small cell carcinoma (adjusted odds ratio 2.72, 95% confidence interval 1.32-5.90). The risks noted for the variant CYP1A1 genotypes and the GSTM1*O/*O genotype seemed to be restricted to light smokers. The GSTT1*O/*O genotype also appeared to be a possible risk factor in light smokers, whereas, in heavy smokers, this genotype was associated with decreased risk for lung cancer overall (odds ratio 0.36, 95% confidence interval 0.13-0.99). Due to the multiple comparisons made, we cannot exclude the possibility that some of these associations may represent chance findings.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Small Cell - epidemiology</subject><subject>Carcinoma, Small Cell - genetics</subject><subject>Carcinoma, Squamous Cell - epidemiology</subject><subject>Carcinoma, Squamous Cell - genetics</subject><subject>Case-Control Studies</subject><subject>Cytochrome P-450 CYP1A1 - genetics</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Genetic Predisposition to Disease</subject><subject>Genotype</subject><subject>Glutathione Transferase - genetics</subject><subject>Humans</subject><subject>Lung Neoplasms - epidemiology</subject><subject>Lung Neoplasms - genetics</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>NAD(P)H Dehydrogenase (Quinone) - genetics</subject><subject>Pneumology</subject><subject>Polymorphism, Genetic</subject><subject>Risk Factors</subject><subject>Smoking - adverse effects</subject><subject>Smoking - genetics</subject><subject>Sweden - epidemiology</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>1055-9965</issn><issn>1538-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkU2P0zAQhiMEYpeFP8AB-cJyIcWOa8c-rgKUlQq70HLgZLnOeGuaxMFuqPbAf8dpysfF86Fn3rHmzbLnBM8IYeINwYzlUnI2k1jMCJ3xB9k5YVTkZcnYw5T_Ac6yJzF-xxiXkrHH2RlhRMyLOTvPfl13thmgM4C8RdW3W3JFXqPFav1xCusUdFejT59vCFpA5_f3PcRjqxraodF79xPQqvU7192htz4mnQ4th1RUOqkG9MXFHXId0mh1gNrFLbr1_XHQd0-zR1Y3EZ6d4kX29f27dfUhX94srqurZW6olPucywJjAoaVlFjCJOWmpgakKAjU6TVSaAu8BiH0xtbCcq610IRbBqQkc3qR5ZNuPEA_bFQfXKvDvfLaqVNrlzJQTLCCF4m_nPg--B8DxL1qXTTQNLoDP0RVpv-wApcJLCbQBB9jAPtXmmA1mqRGD9TogUomKUIVT0MvTurDpoX638jJlQS8PAE6Gt3YkC7p4n-coJyJcfuridu6u-3BBVDmePMAEXQw2-O6cS_9DUwnpcM</recordid><startdate>20040601</startdate><enddate>20040601</enddate><creator>ALEXANDRIE, Anna-Karin</creator><creator>NYBERG, Fredrik</creator><creator>WARHOLM, Margareta</creator><creator>RANNUG, Agneta</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>20040601</creationdate><title>Influence of CYP1A1, GSTM1, GSTT1, and NQO1 Genotypes and Cumulative Smoking Dose on Lung Cancer Risk in a Swedish Population</title><author>ALEXANDRIE, Anna-Karin ; NYBERG, Fredrik ; WARHOLM, Margareta ; RANNUG, Agneta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-692001ec5731f15936cd3ce9821ed982c98afe6de88abfd8f66aa8a16f5e17143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Small Cell - epidemiology</topic><topic>Carcinoma, Small Cell - genetics</topic><topic>Carcinoma, Squamous Cell - epidemiology</topic><topic>Carcinoma, Squamous Cell - genetics</topic><topic>Case-Control Studies</topic><topic>Cytochrome P-450 CYP1A1 - genetics</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Genetic Predisposition to Disease</topic><topic>Genotype</topic><topic>Glutathione Transferase - genetics</topic><topic>Humans</topic><topic>Lung Neoplasms - epidemiology</topic><topic>Lung Neoplasms - genetics</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>NAD(P)H Dehydrogenase (Quinone) - genetics</topic><topic>Pneumology</topic><topic>Polymorphism, Genetic</topic><topic>Risk Factors</topic><topic>Smoking - adverse effects</topic><topic>Smoking - genetics</topic><topic>Sweden - epidemiology</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ALEXANDRIE, Anna-Karin</creatorcontrib><creatorcontrib>NYBERG, Fredrik</creatorcontrib><creatorcontrib>WARHOLM, Margareta</creatorcontrib><creatorcontrib>RANNUG, Agneta</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Cancer epidemiology, biomarkers &amp; prevention</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ALEXANDRIE, Anna-Karin</au><au>NYBERG, Fredrik</au><au>WARHOLM, Margareta</au><au>RANNUG, Agneta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of CYP1A1, GSTM1, GSTT1, and NQO1 Genotypes and Cumulative Smoking Dose on Lung Cancer Risk in a Swedish Population</atitle><jtitle>Cancer epidemiology, biomarkers &amp; prevention</jtitle><addtitle>Cancer Epidemiol Biomarkers Prev</addtitle><date>2004-06-01</date><risdate>2004</risdate><volume>13</volume><issue>6</issue><spage>908</spage><epage>914</epage><pages>908-914</pages><issn>1055-9965</issn><eissn>1538-7755</eissn><abstract>The major identified risk factor for lung cancer is tobacco smoking. We identified previously the possible modifying influence of CYP1A1 and GSTM1 polymorphisms on lung cancer risk in a Swedish population. The present study, extended by several study subjects and with analyses for polymorphisms in GSTT1 and NQO1 , includes 524 lung cancer cases and 530 control subjects. No evidence for an influence of genetic polymorphisms in CYP1A1 , GSTM1 , GSTT1 , and NQO1 on lung cancer risk overall was found. In smokers, there was, however, a suggestion that the variant CYP1A1 and NQO1 genotypes may confer an increased risk for squamous cell carcinoma. In ever smokers, the homozygously deleted GSTM1 ( GSTM1*O/*O ) genotype was significantly associated with increased risk of small cell carcinoma (adjusted odds ratio 2.72, 95% confidence interval 1.32-5.90). The risks noted for the variant CYP1A1 genotypes and the GSTM1*O/*O genotype seemed to be restricted to light smokers. The GSTT1*O/*O genotype also appeared to be a possible risk factor in light smokers, whereas, in heavy smokers, this genotype was associated with decreased risk for lung cancer overall (odds ratio 0.36, 95% confidence interval 0.13-0.99). Due to the multiple comparisons made, we cannot exclude the possibility that some of these associations may represent chance findings.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>15184245</pmid><doi>10.1158/1055-9965.908.13.6</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1055-9965
ispartof Cancer epidemiology, biomarkers & prevention, 2004-06, Vol.13 (6), p.908-914
issn 1055-9965
1538-7755
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_585262
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research
subjects Adult
Aged
Aged, 80 and over
Biological and medical sciences
Carcinoma, Small Cell - epidemiology
Carcinoma, Small Cell - genetics
Carcinoma, Squamous Cell - epidemiology
Carcinoma, Squamous Cell - genetics
Case-Control Studies
Cytochrome P-450 CYP1A1 - genetics
Dose-Response Relationship, Drug
Female
Genetic Predisposition to Disease
Genotype
Glutathione Transferase - genetics
Humans
Lung Neoplasms - epidemiology
Lung Neoplasms - genetics
Male
Medical sciences
Middle Aged
NAD(P)H Dehydrogenase (Quinone) - genetics
Pneumology
Polymorphism, Genetic
Risk Factors
Smoking - adverse effects
Smoking - genetics
Sweden - epidemiology
Tumors of the respiratory system and mediastinum
title Influence of CYP1A1, GSTM1, GSTT1, and NQO1 Genotypes and Cumulative Smoking Dose on Lung Cancer Risk in a Swedish Population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T23%3A48%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20CYP1A1,%20GSTM1,%20GSTT1,%20and%20NQO1%20Genotypes%20and%20Cumulative%20Smoking%20Dose%20on%20Lung%20Cancer%20Risk%20in%20a%20Swedish%20Population&rft.jtitle=Cancer%20epidemiology,%20biomarkers%20&%20prevention&rft.au=ALEXANDRIE,%20Anna-Karin&rft.date=2004-06-01&rft.volume=13&rft.issue=6&rft.spage=908&rft.epage=914&rft.pages=908-914&rft.issn=1055-9965&rft.eissn=1538-7755&rft_id=info:doi/10.1158/1055-9965.908.13.6&rft_dat=%3Cproquest_swepu%3E72005207%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72005207&rft_id=info:pmid/15184245&rfr_iscdi=true